Regulation of microRNAs in coronary atherosclerotic plaque
- PMID: 31596136
- DOI: 10.2217/epi-2019-0036
Regulation of microRNAs in coronary atherosclerotic plaque
Abstract
Aim: Identification of microRNAs (miRNAs) associated with atherosclerosis may unravel novel therapeutic targets and biomarkers. We studied miRNAs differentially expressed between coronary atherosclerotic plaques (CAP) and healthy arteries. Materials & methods: Paired CAP and internal mammary arteries (IMA) were collected from 14 coronary artery disease patients. The miRNA profiles between diseased (CAP) and healthy (IMA) tissues were compared using microarrays and quantitative PCR. Results: Thirty-one miRNAs were differentially expressed between CAP and IMA. Among these, miR-486-5p showed a high level of regulation (12-fold), had predicted interactions with atherosclerosis-associated genes and correlated with triglyceride levels and arterial stenosis. Regulation of miR-486-5p was validated by PCR (p = 0.004). Conclusion: The miRNAs are regulated in the atherosclerotic plaque. We highlight miR-486-5p whose role in atherosclerosis requires further investigation.
Keywords: atherosclerosis; atherosclerotic plaque; coronary artery disease; microRNAs.
Similar articles
-
MicroRNA expression profile of human advanced coronary atherosclerotic plaques.Sci Rep. 2018 May 18;8(1):7823. doi: 10.1038/s41598-018-25690-4. Sci Rep. 2018. PMID: 29777114 Free PMC article.
-
miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study.Atherosclerosis. 2011 Nov;219(1):211-7. doi: 10.1016/j.atherosclerosis.2011.07.020. Epub 2011 Jul 22. Atherosclerosis. 2011. PMID: 21820659
-
Unique MicroRNA signatures associated with early coronary atherosclerotic plaques.Biochem Biophys Res Commun. 2015 Aug 21;464(2):574-9. doi: 10.1016/j.bbrc.2015.07.010. Epub 2015 Jul 6. Biochem Biophys Res Commun. 2015. PMID: 26159918
-
MicroRNAs in the atherosclerotic plaque.Clin Chem. 2013 Dec;59(12):1708-21. doi: 10.1373/clinchem.2013.204917. Epub 2013 May 31. Clin Chem. 2013. PMID: 23729638 Review.
-
MicroRNA Regulation of Atherosclerosis.Circ Res. 2016 Feb 19;118(4):703-20. doi: 10.1161/CIRCRESAHA.115.306300. Circ Res. 2016. PMID: 26892968 Free PMC article. Review.
Cited by
-
Differential Expression of LOXL1-AS1 in Coronary Heart Disease and its Regulatory Mechanism in ox-LDL-Induced Human Coronary Artery Endothelial Cell Pyroptosis.Cardiovasc Drugs Ther. 2023 Feb;37(1):75-87. doi: 10.1007/s10557-021-07274-z. Epub 2021 Oct 11. Cardiovasc Drugs Ther. 2023. Retraction in: Cardiovasc Drugs Ther. 2024 Oct;38(5):1071. doi: 10.1007/s10557-024-07601-0. PMID: 34633594 Retracted.
-
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis.Mol Diagn Ther. 2023 Sep;27(5):601-610. doi: 10.1007/s40291-023-00659-w. Epub 2023 Jun 22. Mol Diagn Ther. 2023. PMID: 37347334
-
circRNA‑0006896‑miR1264‑DNMT1 axis plays an important role in carotid plaque destabilization by regulating the behavior of endothelial cells in atherosclerosis.Mol Med Rep. 2021 May;23(5):311. doi: 10.3892/mmr.2021.11950. Epub 2021 Mar 2. Mol Med Rep. 2021. PMID: 33649864 Free PMC article.
-
MicroRNA-486-5p functions as a diagnostic marker for carotid artery stenosis and prevents endothelial dysfunction through inhibiting inflammation and oxidative stress.Bioengineered. 2022 Apr;13(4):8667-8675. doi: 10.1080/21655979.2022.2054500. Bioengineered. 2022. PMID: 35322734 Free PMC article.
-
Serum‑derived exosomal hsa‑let‑7b‑5p as a biomarker for predicting the severity of coronary stenosis in patients with coronary heart disease and hyperglycemia.Mol Med Rep. 2023 Nov;28(5):203. doi: 10.3892/mmr.2023.13090. Epub 2023 Sep 15. Mol Med Rep. 2023. PMID: 37711034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
